Certified-Pep | GHK-Cu 100mg Lyophilized Vial
EGP11,099.00
Certified-Pep GHK-Cu 100mg is a lyophilized copper-tripeptide material supplied exclusively for controlled laboratory research and analytical characterization.
- 100mg Research Vial: Defined label quantity of lyophilized GHK-Cu.
- Current Batch COA: Purity, quantity and chromatographic documentation available.
- Multi-Panel Testing: Includes contaminant, endotoxin and sterility analysis.
- Copper-Peptide Research: Suitable for controlled matrix and signaling models.
- Strict RUO Classification: Not for human or veterinary use.
Certified-Pep GHK-Cu 100mg is a lyophilized copper-tripeptide preparation supplied exclusively as a controlled laboratory research material. GHK represents the amino-acid sequence Gly-His-Lys, which can coordinate copper to form the biochemical complex commonly called GHK-Cu. The compound has been examined in analytical, cell-culture and preclinical models involving copper coordination, extracellular-matrix signaling, redox pathways and peptide characterization. Those research settings do not establish clinical effectiveness, human safety or suitability for personal administration, and this vial must not be used for ingestion, injection, topical application, veterinary purposes, diagnosis or treatment.
The Science of Certified-Pep GHK-Cu 100mg Research
GHK-Cu is a coordination complex in which the short tripeptide Gly-His-Lys binds a copper ion. Its behavior depends on molecular identity, copper stoichiometry, purity, concentration, experimental conditions and the analytical controls used by the laboratory.
Copper-Binding Tripeptide Identity: The histidine-containing peptide sequence can coordinate copper and form a chemically distinct copper-peptide complex. Research workflows may examine binding behavior, solution stability, spectral properties and interactions with defined biological models.
Extracellular-Matrix Research Context: Published mechanistic literature has explored GHK-Cu in relation to fibroblast activity and the expression of collagen, elastin and glycosaminoglycan-associated pathways. These findings are largely model-dependent and cannot be converted into a personal skincare, wound or hair-growth protocol.
Batch-Level Analytical Verification: Certified-Pep links the product to batch-specific purity, quantity, contaminant, endotoxin and sterility testing. Researchers should evaluate the received lot documentation directly because website descriptions and results from earlier lots cannot replace the actual COA.
Key Research Features of Certified-Pep GHK-Cu 100mg
- Defined Research Material: Supplied as a labelled 100 mg lyophilized vial.
- High Chromatographic Purity: Current linked batch reports greater than 99.80% purity.
- Quantity Verification: Current linked batch reports 112.36 mg by HPLC analysis.
- Contaminant Screening: Current documentation includes metals, endotoxin and sterility panels.
- Clear Research Restriction: Explicitly excluded from human and veterinary applications.
Explore GHK-Cu and controlled laboratory research materials at Egypt Vitamins.

Specifications
Laboratory Handling Guide
Upon receipt, inspect the vial seal, product label, lot number and all accompanying documentation. Compare the received lot with the corresponding purity, quantity and contaminant reports before beginning analytical work. Use only validated institutional procedures, calibrated equipment and laboratory-appropriate containment and personal protective equipment. The reviewed product page does not provide a validated reconstitution procedure or exact storage temperature, so no generic solvent, concentration or freezer condition should be assumed. The lot-specific COA, supplier documentation, Safety Data Sheet and institutional standard operating procedure must take priority.
Safety and Regulatory Information
This vial is labelled for Research Use Only and is not a dietary supplement, cosmetic, medicine, approved drug or consumer product. Do not ingest, inject, inhale or apply it to a person or animal. Laboratory personnel should follow suitable containment, spill-management and waste-disposal procedures. FDA has stated that compounded injectable GHK-Cu may present immunogenicity concerns because of aggregation and peptide-related impurities, while human safety information remains limited. The warning applies specifically to compounded injectable preparations, but it reinforces the need to prohibit personal or clinical use. Batch analytical results demonstrate characteristics of the tested sample only and should not be interpreted as approval for administration.
Review FDA information concerning potential risks associated with compounded injectable GHK-Cu.
Frequently Asked Questions
What is GHK-Cu?
Can this vial be injected, ingested or applied to the skin?
How should researchers verify the product?
Why does the current COA report more than the labelled 100 mg?
Research-Use Disclaimer
This product is supplied for laboratory and research use only. It is not a dietary supplement, not a medicine, and is not intended for human or veterinary consumption. It has not been evaluated for the diagnosis, treatment, cure or prevention of any disease.
Sold to qualified researchers and professionals only, and must be handled in an appropriate research setting.



Reviews
There are no reviews yet.